Related Experiment Videos
Fetal growth restriction: the etiology
1Department of Obstetrics and Gynecology, Winthrop University Hospital, 259 First Street, Mineola, New York 11501, USA. wirving@winthrop.org
Clinical Obstetrics and Gynecology
|May 25, 2006
Summary
Fetal growth restriction (FGR) involves maternal, fetal, and placental factors. Understanding these causes can improve FGR prediction, prevention, and management.
Area of Science:
- Obstetrics and Gynecology
- Perinatology
- Developmental Biology
Background:
- Fetal growth restriction (FGR) is a significant obstetric complication with diverse etiologies.
- Identifying the specific causes of FGR is crucial for effective clinical management.
- Existing knowledge links FGR to maternal, fetal, and placental factors, but associations are not always present.
Purpose of the Study:
- To comprehensively review the etiologic factors associated with Fetal Growth Restriction (FGR).
- To elucidate the roles of maternal, fetal, and placental conditions in the development of FGR.
- To highlight the importance of understanding FGR etiologies for improved clinical outcomes.
Main Methods:
- Systematic literature review of studies investigating Fetal Growth Restriction (FGR) etiologies.
- Analysis of maternal, fetal, and placental factors implicated in FGR.
- Synthesis of current evidence on the association between various factors and FGR.
Main Results:
- Maternal factors contributing to FGR include hypertensive diseases, autoimmune disorders, malnutrition, and lifestyle choices (smoking, alcohol, cocaine).
- Fetal etiologies encompass aneuploidy, malformations, genomic imprinting syndromes, infections, preterm birth, and multiple gestation.
- Placental factors involve anatomical, vascular, chromosomal, and morphological abnormalities.
Conclusions:
- Fetal growth restriction (FGR) arises from a complex interplay of maternal, fetal, and placental factors.
- A thorough understanding of these diverse etiologies is essential for advancing the prediction and prevention of FGR.
- Further research into the specific mechanisms underlying FGR may lead to improved therapeutic strategies.
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...